市場調查報告書
商品編碼
1198315
性別確認手術市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)Sex Reassignment Surgery Market - Growth, Trends, and Forecasts (2023 - 2028) |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
變性手術市場預計在預測期內(2022 年至 2027 年)將以 12.2% 的複合年增長率增長。
COVID-19 正在影響所研究市場的增長速度。 美國整形與重建外科學會 2020 年 5 月發表的一篇題為“COVID-19 對性別不安患者的影響”的文章指出,變性手術被視為擇期手術,因此停止或推遲手術。據悉, 還包括一篇整形和重建外科論文,題為“基於 COVID-19 的手術暫停對整形外科實踐的影響”。 在 2020 年 8 月公佈的“ACAPS 會員調查”中,據報導,32% 的受訪者接受過性別確認手術。 另據報導,由於 COVID-19,未進行面部、胸部和生殖器手術。 它還指出,將近 8% 的人回答說性別再確認手術是視情況而定的。 由於 COVID-19 而導致的這些手術的延誤影響了大流行期間整個市場的增長。
諸如變性手術意識的增強、性別不安的負擔以及政府舉措等因素正在推動市場的增長。 例如,美國整形外科醫師學會題為《2020 年整形外科統計報告》的報告發現,2020 年美國為跨性別女性進行了 6,368 例性別確認手術,而 2019 年為 5,616 例。據報導,有 另據報導,2020 年,其中 1,102 例是面部手術,4,035 例是乳房或胸部手術,1,231 例是生殖器手術。 此外,根據國際美容外科醫生協會2020年的統計數據,2020年全球有9.2%的整形外科醫生進行了變性手術。 如此多的性別確認手術表明市場在整個預測期內呈正增長。
各國政府為跨性別健康提供財政支持、平等權利和支持的舉措正在推動該細分市場的增長。 例如,2020年11月,印度政府制定實施2019年跨性別者(權利保護)法案的規定,根據該法案,該中心將在每個邦免費提供至少一所政府醫院,擬配備提供變性手術和諮詢服務。
此外,2021 年 11 月,澳大利亞綠黨將承諾每年投入 1500 萬美元,用於支付跨性別者和性別多元化者在獲得對性別敏感的醫療保健方面產生的自付費用。宣布了投資計劃,以Medicare 中永久性的性別敏感護理。 政府和公共機構的此類舉措正在推動市場的增長。
但是,高加工成本可能會阻礙預測期內的市場增長。
在預測期內,性別不安負擔的增加、變性手術意識的增強、政府的舉措以及手術數量的增加等因素正在推動市場增長。
男性性別不安的高患病率導致男性對女性手術的採用,從而推動了細分市場的增長。 例如,Scientific Reports 的一篇題為“瑞典性別不安診斷的有效性和發病率趨勢:2021 年 8 月發表的全國登記研究”的論文發現,歐洲、美國和澳大利亞的調查參與者中性別不安的總體患病率是據報導,每萬人口中有0.46人,其中男性0.68人,女性0.26人。 如此高的男性性別焦慮症患病率將在預測期內推動變性手術市場的男性到女性部分。
此外,在美國整形外科學會題為“整形外科統計報告”的2020年報告中,2020年美國進行了9,985例男性變性手術,而2019年為8,986例。據報導,有案件 越來越多地採用手術標誌著細分市場的增長。
此外,政府機構的支持也在推動市場的增長。 例如,根據 2022 年 3 月的最新消息,新西蘭衛生部報告稱,性別確認(生殖器)手術服務的成立是為了讓更多的跨性別者能夠在新西蘭獲得公共資助的性別確認性生殖器手術。我在這裡。 該服務已在 2019 年預算中批准了四年的 299 萬美元,以補充來自高成本治療池的資金分配,用於確認性別的生殖器手術。 這筆資金預計每年最多可以進行 14 次手術。 來自各個政府機構的這種支持正在推動市場的增長。
因此,由於上述因素,預計該細分市場在預測期內將出現可觀的增長。
由於性別不安的負擔不斷增加、變性手術的意識和採用率不斷提高以及政府和公共機構的支持,預計北美地區將在變性手術市場中佔據重要份額。
在該地區進行的手術數量不斷增加表明該地區的市場正在增長。 例如,美國疾病控制與預防中心 2021 年 7 月更新的一篇題為“跨性別者和性別多樣化的人”的文章報告說,美國每年大約進行 9,000 例跨性別手術。。 最新統計數據還顯示,0.6% 的美國人口被確定為變性人,近 10.9% 的變性醫療經歷導致性別確認手術。 如此多的手術表明市場的顯著增長。
此外,政府對外科手術的護理和財政支持等支持也在推動市場的增長。 例如,2021 年 6 月,退伍軍人事務部 (VA) 部長丹尼斯·麥克唐納 (Dennis McDonagh) 在佛羅裡達州舉行的 Pride 活動中宣布,美國政府將首次允許變性退伍軍人通過醫療保險進行性別確認手術。) 報導了這一變化。 到目前為止,僅涵蓋激素治療和心理健康服務。 這些政府措施正在推動市場的增長。
因此,由於上述因素,預計北美地區在預測期內將出現增長。
The sex reassignment surgery market is expected to witness a CAGR of 12.2% over the forecast period (2022-2027).
COVID-19 has impacted the growth pace of the studied market. The American Society of Plastic Surgeons article titled "The Impact of COVID-19 on Gender Dysphoria Patients" published in May 2020 reported that since gender-affirming surgeries are considered one of the elective surgeries, they have been halted or delayed. Additionally, the Plastic and Reconstructive Surgery article titled "The Impact of COVID-19-based Suspension of Surgeries on Plastic Surgery Practices: A Survey of ACAPS Members" published in August 2020, reported that 32% of the studied population performed gender affirmation surgery. It also reported that due to COVID-19, face, chest, and genital surgery were not being offered. It also stated that nearly 8% responded that revision sex reaffirmation surgery was a situation-specific scenario. Such delays in surgeries due to COVID-19 has impacted the growth of the overall market over the pandemic phase.
Factors such as growing awareness about sex reassignment surgery and the burden of gender dysphoria coupled with government initiatives are driving the growth of the market. For instance, the American Society of Plastic Surgeons report titled "Plastic Surgery Statistics Report" 2020 reported that in the United States, in 2020, trans females had 6,368 gender confirmation surgeries performed compared to 5,616 in 2019. It was also reported that in 2020, out of these 1,102 facial surgeries, 4,035 breast or chest surgeries, and 1,231 genital surgeries were performed. Furthermore, according to the International Society of Aesthetic Plastic Surgery 2020 statistics, 9.2 percent of plastic surgeons worldwide performed sex reassignment surgery in 2020. Such a high number of sex confirmation surgeries demonstrates the positive growth of the market throughout the forecast period.
The rising government initiatives of different countries to provide financial aid, equal rights, and support for transgender health are boosting the growth of the market segment. For instance, in November 2020, the government of India framed rules to implement the Transgender Persons (Protection of Rights) Act, 2019, under which the center proposes that at least one government hospital in every state will be equipped to provide free gender reassignment surgery and counseling.
Furthermore, in November 2021, the Australian Greens announced a plan to make gender-affirming healthcare a permanent part of Medicare, with a USD 15 million investment per year to cover the out-of-pocket costs incurred by trans and gender-diverse people in accessing gender-affirming healthcare. Such initiatives taken by the government and public organizations are propelling the growth of the market.
However, the high procedural costs may hinder the growth of the market over the forecast period.
Factors such as the growing burden of gender dysphoria, increasing awareness about gender reaffirmation surgeries, initiatives taken by the government, and the rising number of surgeries are driving the growth of the market over the forecast period.
The high prevalence of gender dysphoria among males leads to the adoption of male-to-female surgery and thus drives the growth of the market segment. For instance, the Scientific Reports article titled "Validity of the Gender Dysphoria diagnosis and incidence trends in Sweden: a nationwide register study published in August 2021" reported that the overall prevalence in the studied population in Europe, the United States, and Australia for gender dysphoria was 0.46/10,000 population, of which 0.68 for birth-assigned males and 0.26 for birth-assigned females. Such a high prevalence of gender dysphoria in males drives the male to female segment of the sex reassignment surgery market over the forecast period.
Additionally, the American Society of Plastic Surgeons report titled "Plastic Surgery Statistics Report" 2020 reported that in the United States, in 2020, trans males had 9,985 gender confirmation surgeries performed compared to 8,986 in 2019. This increasing adoption of surgery is demonstrating the growth of the market segment.
The support from government agencies is also propelling the growth of the market. For instance, as per the March 2022 update, the Ministry of Health, New Zealand reported that a Gender Affirming (Genital) Surgery Service had been established to help more transgender people access publicly-funded gender-affirming genital surgery in New Zealand. The service has been funded with USD 2.99 million approved in Budget 2019 over four years to supplement the allocation of funding from the High-Cost Treatment Pool for gender-affirming genital surgeries. This funding is expected to enable the delivery of up to 14 surgeries per year. Such support from different government agencies is boosting the growth of the market.
Thus, owing to the abovementioned factors, the market segment is expected to show considerable growth over the forecast period.
The North American region is expected to hold a significant share in the sex reassignment surgery market owing to the rising burden of gender dysphoria, increasing awareness and adoption of gender reassignment surgery, coupled with the support of government and public organizations.
The growing number of surgeries performed in the region demonstrates the growth of the market in the region. For instance, the Center for Disease Control and Prevention article titled "Transgender and Gender Diverse Persons", updated in July 2021, reported that about 9,000 transgender surgeries are being performed annually across the United States. It also reported that the latest statistics indicate that 0.6% of the United States population identifies as transgender, and nearly 10.9% of medical encounters with transsexualism result in gender-affirming surgeries. Such a high number of surgeries performed in the country depicts significant growth in the market.
Additionally, support from the government, such as care and financial aid for surgical procedures, is also propelling the growth of the market. For instance, in June 2021, Department of Veterans Affairs (VA) secretary Denis McDonough reported the change at a Pride event in Florida that the United States government will offer gender confirmation surgery (Gender Affirmation surgery) for transgender veterans through its health care coverage for the first time. Earlier, only hormone therapy and mental health services were covered under this. Such steps taken by the government are propelling the growth of the market.
Thus, owing to the abovementioned factors, the North American region is expected to show growth over the forecast period.
The sex reassignment surgery market is a moderately competitive market consisting of a few major players. In terms of market share, private players have a larger share. With the rising government initiatives, market players focusing on the patient-centric approach are major factors propelling the market. Some of the key market players in this market include Mount Sinai, Phuket Plastic Surgery Institute, IM Gender Clinic, CNY Cosmetic and Reconstructive Surgerym, and Boston Medical Center.